OSI Systems Reports Fiscal 2022 First Quarter Financial Results
OSI Systems reported Q1 revenues of $279.3 million, a 10% increase year-over-year. GAAP earnings per diluted share were $1.04, while non-GAAP EPS reached $1.16, marking a 9% growth. The book-to-bill ratio stood at 1.6 and backlog rose to $1.2 billion, up 15% from June 2021. Despite supply chain challenges, the Security division saw an 11% revenue growth. The company maintains its FY 2022 revenue guidance of $1.190 - $1.225 billion and non-GAAP EPS guidance of $5.72 - $6.00.
- 10% increase in Q1 revenue year-over-year
- GAAP EPS of $1.04 and non-GAAP EPS of $1.16, up 9% year-over-year
- Book-to-bill ratio of 1.6 indicates strong demand
- Backlog increased 15% to $1.2 billion
- Cash used in operations was $11 million due to inventory investment and working capital timing issues
-
Q1 Revenues of
($279 Million 10% year-over-year increase) -
Q1 Earnings Per Diluted Share
-
GAAP EPS of
$1.04 -
Non-GAAP EPS of
($1.16 9% year-over-year increase)
-
GAAP EPS of
-
Q1 Book-to-
Bill Ratio of 1.6 -
Q1 Backlog Increased to
($1.2 Billion 15% increase fromJune 30, 2021 ) - Company Reiterates FY 2022 Guidance
The Company reported revenues of
For the quarter ended
Fiscal Year 2022 Outlook
|
Guidance |
|
|
|
|
Revenues |
|
|
|
|
|
Non-GAAP Diluted Earnings Per Share |
|
|
|
|
The Company is reiterating its fiscal year 2022 revenues and non-GAAP diluted earnings per share guidance. Actual revenues and non-GAAP diluted earnings per share could vary from this guidance due to factors discussed under “Forward-Looking Statements” or other factors, including uncertainties as to the duration and future scope of the COVID-19 pandemic.
The Company’s fiscal 2022 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of non-GAAP diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected non-GAAP diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for the three months ended
Reconciliations of GAAP to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, operational performance and impact of the COVID-19 pandemic in fiscal 2022 and beyond. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; global economic uncertainty; impact on the Company’s business related to or resulting from the COVID-19 pandemic such as material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on the Company’s ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of the Company's new and existing technologies, products, and services; the Company's ability to win new business and convert orders received to sales within the fiscal year; enforcement actions in respect of any noncompliance with laws and regulations, including export control and environmental regulations and the matters that are the subject of some or all of the Company's investigations and compliance reviews; contract and regulatory compliance matters, and actions which, if brought, could result in judgments, settlements, fines, injunctions, debarment, or penalties; and other risks and uncertainties, including, but not limited to, those detailed herein and from time to time in the Company's
|
||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||
(in thousands, except per share data) |
||||||||
|
|
|
||||||
|
|
Three Months Ended
|
||||||
|
|
2020 |
|
2021 |
||||
|
|
|
||||||
Revenues: |
|
|
||||||
Products |
$ |
182,747 |
|
$ |
207,212 |
|
||
Services |
72,161 |
|
72,045 |
|
||||
Total revenues |
254,908 |
|
279,257 |
|
||||
Cost of goods sold: |
|
|
||||||
Products |
124,841 |
|
142,906 |
|
||||
Services |
34,316 |
|
37,021 |
|
||||
Total cost of goods sold |
159,157 |
|
179,927 |
|
||||
Gross profit |
95,751 |
|
99,330 |
|
||||
Operating expenses: |
|
|
||||||
Selling, general and administrative |
58,617 |
|
57,323 |
|
||||
Research and development |
12,082 |
|
14,817 |
|
||||
Impairment, restructuring and other charges, net |
8,359 |
|
2,510 |
|
||||
Total operating expenses |
79,058 |
|
74,650 |
|
||||
Income from operations |
16,693 |
|
24,680 |
|
||||
Interest and other expense, net |
(4,189 |
) |
(2,016 |
) |
||||
Income before income taxes |
12,504 |
|
22,664 |
|
||||
Provision for income taxes |
(3,160 |
) |
(3,612 |
) |
||||
Net income |
$ |
9,344 |
|
$ |
19,052 |
|
||
|
|
|
||||||
Diluted earnings per share |
$ |
0.51 |
|
$ |
1.04 |
|
||
Weighted average shares outstanding – diluted |
18,335 |
|
18,306 |
|
||||
|
||||||||
UNAUDITED SEGMENT INFORMATION |
||||||||
(in thousands) |
||||||||
|
|
|
||||||
|
|
Three Months Ended
|
||||||
|
2020 |
|
2021 |
|||||
Revenues – by Segment: |
|
|
||||||
Security division |
$ |
134,775 |
|
$ |
149,517 |
|
||
Healthcare division |
51,503 |
|
50,588 |
|
||||
Optoelectronics and Manufacturing division, including intersegment revenues |
79,914 |
|
92,305 |
|
||||
Intersegment eliminations |
(11,284 |
) |
(13,153 |
) |
||||
Total |
$ |
254,908 |
|
$ |
279,257 |
|
||
|
|
|
||||||
Operating income (loss) – by Segment: |
|
|
||||||
Security division |
$ |
8,906 |
|
$ |
21,593 |
|
||
Healthcare division |
8,984 |
|
5,920 |
|
||||
Optoelectronics and Manufacturing division |
8,740 |
|
9,783 |
|
||||
Corporate |
(9,456 |
) |
(12,463 |
) |
||||
Intersegment eliminations |
(481 |
) |
(153 |
) |
||||
Total |
$ |
16,693 |
|
$ |
24,680 |
|
||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(in thousands) |
||||||
|
|
|
|
|
||
|
|
|
|
|
||
Assets |
|
|
||||
|
|
|
||||
Cash and cash equivalents |
$ |
80,613 |
$ |
54,663 |
||
Accounts receivable, net |
290,653 |
292,004 |
||||
Inventories |
294,208 |
320,673 |
||||
Other current assets |
43,930 |
62,870 |
||||
Total current assets |
709,404 |
730,210 |
||||
Property and equipment, net |
118,004 |
116,814 |
||||
|
320,304 |
319,345 |
||||
Intangible assets, net |
127,608 |
127,262 |
||||
Other non-current assets |
109,047 |
117,008 |
||||
Total Assets |
$ |
1,384,367 |
$ |
1,410,639 |
||
|
|
|
||||
Liabilities and Stockholders' Equity |
|
|
||||
|
|
|
||||
Bank lines of credit |
$ |
-- |
$ |
26,000 |
||
Current portion of long-term debt |
846 |
286,954 |
||||
Accounts payable and accrued expenses |
210,077 |
221,434 |
||||
Other current liabilities |
133,844 |
122,400 |
||||
Total current liabilities |
344,767 |
656,788 |
||||
Long-term debt |
276,421 |
692 |
||||
Other long-term liabilities |
123,359 |
129,847 |
||||
Total liabilities |
744,547 |
787,327 |
||||
Total stockholders’ equity |
639,820 |
623,312 |
||||
Total Liabilities and Stockholders’ Equity |
$ |
1,384,367 |
$ |
1,410,639 |
||
|
||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP |
||||||||||||||||
NET INCOME AND EARNINGS PER SHARE |
||||||||||||||||
(in thousands, except earnings per share data) |
||||||||||||||||
|
|
|
||||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
2020 |
|
2021 |
||||||||||||
|
|
Net income |
|
Diluted EPS |
|
Net income |
|
Diluted EPS |
||||||||
GAAP basis |
$ |
9,344 |
|
$ |
0.51 |
|
$ |
19,052 |
|
$ |
1.04 |
|
||||
Impairment, restructuring and other charges (benefit), net |
|
8,359 |
|
|
0.46 |
|
|
2,510 |
|
|
0.14 |
|
||||
Amortization of acquired intangible assets |
|
3,776 |
|
|
0.21 |
|
|
3,198 |
|
|
0.18 |
|
||||
Non-cash interest expense |
|
2,226 |
|
|
0.12 |
|
|
68 |
|
|
0.00 |
|
||||
Tax effect of above adjustments |
|
(3,946 |
) |
|
(0.22 |
) |
|
(1,467 |
) |
|
(0.08 |
) |
||||
Impact from discrete income tax items |
|
(276 |
) |
|
(0.02 |
) |
|
(2,145 |
) |
|
(0.12 |
) |
||||
Non-GAAP basis |
$ |
19,483 |
|
$ |
1.06 |
|
$ |
21,216 |
|
$ |
1.16 |
|
||||
RECONCILIATION OF GAAP TO NON-GAAP |
||||||||||||||||||||||||||||
OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT |
||||||||||||||||||||||||||||
(in thousands, except percentages) |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||||||||||
|
|
Security
|
|
Healthcare
|
|
Optoelectronics and
|
|
Corporate /
|
|
Total |
||||||||||||||||||
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
% of
|
|
|
|
|
|
% of
|
||||||||||
GAAP basis – operating income (loss) |
$ |
8,906 |
6.6 |
% |
$ |
8,984 |
17.4 |
% |
$ |
8,740 |
10.9 |
% |
$ |
(9,937 |
) |
$ |
16,693 |
6.5 |
% |
|||||||||
Restructuring and other charges (benefit), net |
|
8,253 |
6.1 |
|
|
- |
- |
|
|
146 |
0.2 |
|
|
(40 |
) |
|
8,359 |
3.3 |
|
|||||||||
Amortization of acquired intangible assets |
|
2,813 |
2.1 |
|
|
202 |
0.4 |
|
|
761 |
1.0 |
|
|
- |
|
|
3,776 |
1.5 |
|
|||||||||
Non-GAAP basis– operating income (loss) |
$ |
19,972 |
14.8 |
% |
$ |
9,186 |
17.8 |
% |
$ |
9,647 |
12.1 |
% |
$ |
(9,977 |
) |
$ |
28,828 |
11.3 |
% |
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Three Months Ended |
||||||||||||||||||||||||||||
|
|
Security
|
|
Healthcare
|
|
Optoelectronics and
|
|
Corporate /
|
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
$ |
21,593 |
14.4 |
% |
$ |
5,920 |
11.7 |
% |
$ |
9,783 |
10.6 |
% |
$ |
(12,616 |
) |
$ |
24,680 |
8.8 |
% |
|||||||||
Impairment, restructuring and other charges, net. |
|
275 |
0.2 |
|
|
- |
- |
|
|
- |
- |
|
|
2,235 |
|
|
2,510 |
0.9 |
|
|||||||||
Amortization of acquired intangible assets |
|
2,286 |
1.6 |
|
|
202 |
0.4 |
|
|
710 |
0.8 |
|
|
- |
|
|
3,198 |
1.2 |
|
|||||||||
Non-GAAP basis– operating income (loss) |
$ |
24,154 |
16.2 |
% |
$ |
6,122 |
12.1 |
% |
$ |
10,493 |
11.4 |
% |
$ |
(10,381 |
) |
$ |
30,388 |
10.9 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005321/en/
Vice President, Business Development
Tel: (310) 349-2237
avashishat@osi-systems.com
Source:
FAQ
What were OSI Systems' Q1 revenue results for fiscal 2022?
What are the earnings per share results for OSI Systems' Q1 2022?
What is OSI Systems' guidance for fiscal year 2022?
How much did OSI Systems' backlog increase in Q1 2022?